Bora Hwang

Title: Bora Hwang: Innovator in Fc-gamma Receptor Mutants

Introduction

Bora Hwang is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biotechnology, particularly through his work on Fc-gamma receptor mutants. His innovative approach has the potential to enhance drug efficacy and improve therapeutic outcomes.

Latest Patents

Bora Hwang holds a patent for Fc-gamma receptor mutants. This patent describes a polypeptide that includes an Fc-gamma receptor mutant optimized by substituting parts of its amino acid sequence. This optimization provides an excellent selective binding ability to immunoglobulins. The applications of this invention are vast, including increasing the in vivo half-life of drugs, detecting and purifying immunoglobulins, inhibiting organ transplant rejections, and preventing or treating autoimmune diseases. He has 1 patent to his name.

Career Highlights

Bora Hwang is affiliated with Kookmin University, where he continues to engage in research and development in the field of immunology and biotechnology. His work has garnered attention for its potential impact on medical treatments and drug development.

Collaborations

Bora Hwang collaborates with esteemed colleagues, including Sang Taek Jung and Migyeong Jo, who contribute to his research endeavors. Their combined expertise enhances the quality and scope of their projects.

Conclusion

Bora Hwang's innovative work on Fc-gamma receptor mutants represents a significant advancement in biotechnology. His contributions have the potential to transform therapeutic approaches and improve patient outcomes.